[Therapy of diabetic angiopathies].
D000109:Acetylcholine / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010431:Pentoxifylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014971:Xanthinol Niacinate / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D014971:Xanthinol Niacinate; D006493:Heparin; D000109:Acetylcholine; D010431:Pentoxifylline
Sulla terapia delle angiopatie diabetiche.